RAP 0.00% 20.5¢ resapp health limited

RAP media thread., page-50

  1. 26,625 Posts.
    lightbulb Created with Sketch. 1726
    Also more importantly the time constraint will put less pressure on doctors (especially in resource intensive hospital) to make the correct diagnosis, and given the well known difficulty in diagnosis of respiratory diseases, ResAppDx will assist greatly in this outcome especially with diagnosis of the more common UTRI/LTRI respiratory diseases in the 1st world countries where doctors just prescribe unnecessary antibiotic which will be the biggest threat to human kind this century with the emergence of the super bug due to overuse of antibiotic.

    https://www.ijidonline.com/article/S1201-9712(19)30353-4/fulltext
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.